Stellar

Stellar

The purpose of this study is to evaluate the efficacy and safety of Sotatercept plus background PAH therapy at 24 weeks in adults with pulmonary arterial hypertension (PAH).

Please use this link for further information:

Primary Investigator: Peter Engel

Enrolling
Enroll now

Disclaimer: Patients must have an existing, documented diagnosis to be entered into some trials.
Copyright © 2022 All rights reserved. | Privacy Practices

Web Design by TBH Creative